Literature DB >> 6088156

Angiotensin converting enzyme response to hypoxia in man: its role in altitude acclimatization.

J S Milledge, D M Catley.   

Abstract

The response of serum angiotensin converting enzyme (ACE) activity to three grades of hypoxia was studied in two groups of human subjects. Hypoxic gas mixtures having oxygen concentrations of 14, 12.6 and 10.4% were breathed successively for a period of 10 min at each concentration. Venous blood was sampled at the end of each of the three periods and arterial oxygen saturation was recorded throughout the experiment. The subjects were selected as being 'good' or 'poor' acclimatizers according to their history of acute mountain sickness. There were five subjects in each group. Hypoxia resulted in a reduction in ACE activity in both groups, the reduction being linear with respect to arterial oxygen saturation. The reduction in ACE activity was greater in the good acclimatizer group as shown by a significantly greater slope of the response line of ACE activity to arterial oxygen saturation. The significance of this finding in relation to the mechanism underlying acute mountain sickness is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088156     DOI: 10.1042/cs0670453

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  2 in total

1.  The effects of chronic hypoxia on renal function in the rat.

Authors:  M Neylon; J M Marshall; E J Johns
Journal:  J Physiol       Date:  1997-05-15       Impact factor: 5.182

2.  A pilot investigation into the effects of acute normobaric hypoxia, high altitude exposure and exercise on serum angiotensin-converting enzyme, aldosterone and cortisol.

Authors:  Mark Cooke; Richard Cruttenden; Adrian Mellor; Andrew Lumb; Stewart Pattman; Anne Burnett; Chris Boot; Louise Burnip; Christopher Boos; John O'Hara; David Woods
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2018 Apr-Jun       Impact factor: 1.636

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.